We show that loss of RB1 results in an immunosuppressive tumor microenvironment, and that Rb-deficient tumor cells have increased susceptibility to BET inhibition in terms of tumor cell-intrinsic and extrinsic efficacy. This evidence concerns the gene DNER and neoplasm.